Medical Weight Loss Programs
Evidence-based pharmaceutical interventions for sustainable weight loss. Medically supervised GLP-1 and dual-agonist therapies tailored to your unique metabolic profile and health goals.
Medically Supervised
Regular monitoring by Dr. Kenika with personalized dosage adjustments based on your response and health markers.
Comprehensive Support
Includes nutritional guidance, lifestyle coaching, and ongoing metabolic optimization throughout your journey.
Proven Results
Clinical studies show 15-25% body weight reduction with proper adherence and medical supervision.
Wegovy
(Semaglutide)
FDA-approved GLP-1 receptor agonist for chronic weight management. Clinically proven to help patients achieve significant, sustainable weight loss when combined with lifestyle modifications.
How it works: Works by mimicking the GLP-1 hormone to reduce appetite, slow gastric emptying, and improve blood sugar control.
Personalized Dosing
Available in multiple dosage strengths (0.25 mg, 0.50 mg, 1 mg, 1.7 mg, 2.4 mg). Your personalized dosage and titration schedule will be determined by Dr. Kenika based on your individual response, tolerance, and health goals.
Clinical Benefits
- Average 15-20% body weight reduction in clinical trials
- Improved cardiovascular health markers
- Better glycemic control and insulin sensitivity
- Reduced appetite and food cravings
- Long-term weight maintenance support
- Once-weekly injection for convenience
Monjaro
(Tirzepatide)
Dual GIP/GLP-1 receptor agonist representing the latest advancement in medical weight loss therapy. Superior efficacy compared to single-hormone therapies with enhanced metabolic benefits.
How it works: Activates both GIP and GLP-1 receptors for dual-action metabolic benefits, enhanced appetite suppression, and improved insulin sensitivity.
Personalized Dosing
Available in multiple dosage strengths (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg). Dr. Kenika will create a customized titration plan tailored to your metabolic profile, starting with a lower dose and adjusting based on your progress and tolerance.
Clinical Benefits
- Average 20-25% body weight reduction in clinical trials
- Superior metabolic improvements vs. GLP-1 alone
- Enhanced insulin sensitivity and glucose control
- Significant cardiovascular risk reduction
- Improved lipid profiles (cholesterol, triglycerides)
- Better long-term outcomes and sustainability
Transparent Pricing
Clear, upfront pricing for all dosage levels. Includes medication cost and optional injection service.
Wegovy (Semaglutide)
GLP-1 Receptor Agonist
| Dosage | Medication | Injection |
|---|---|---|
| 0.25 mg | ฿14,990 | ฿1,990 |
| 0.50 mg | ฿15,990 | ฿3,980 |
| 1 mg | ฿16,990 | ฿7,960 |
| 1.7 mg | ฿23,590 | — |
| 2.4 mg | ฿29,990 | — |
Monjaro (Tirzepatide)
Dual GIP/GLP-1 Agonist
| Dosage | Medication | Injection |
|---|---|---|
| 2.5 mg | ฿16,990 | ฿2,190 |
| 5 mg | ฿19,990 | ฿3,690 |
| 7.5 mg | ฿26,990 | ฿5,490 |
| 10 mg | ฿32,990 | ฿8,490 |
| 12.5 mg | ฿36,990 | — |
| 15 mg | ฿36,990 | — |
Note: Injection service is optional. Prices are per dose. Weekly injections required. Your personalized treatment plan and total program cost will be discussed during consultation with Dr. Kenika.
Individualized Medical Care
All weight loss medications require medical supervision and are prescribed only after comprehensive evaluation. Dr. Kenika will assess your medical history, current health status, metabolic markers, and weight loss goals to determine the most appropriate medication and dosing strategy for you.
Dosage titration schedules are individualized based on your tolerance, side effects, and weight loss progress. Regular follow-ups ensure optimal results while minimizing potential adverse effects.